{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:41:38Z","timestamp":1772710898097,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40644-017-0130-8","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T07:19:58Z","timestamp":1510039198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["How we read pediatric PET\/CT: indications and strategies for image acquisition, interpretation and reporting"],"prefix":"10.1186","volume":"17","author":[{"given":"Gabrielle C.","family":"Colleran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Oberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick D.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Drubach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Callahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"MacDougall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic H.","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan D.","family":"Voss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,7]]},"reference":[{"issue":"10","key":"130_CR1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4329\/wjr.v6.i10.741","volume":"6","author":"J Freebody","year":"2014","unstructured":"Freebody J, Wegner EA, Rossleigh MA. 2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography\/computed tomography imaging in paediatric oncology. World J Radiol. 2014;6(10):741\u201355.","journal-title":"World J Radiol"},{"issue":"3","key":"130_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.semnuclmed.2016.12.004","volume":"47","author":"DJ Harrison","year":"2017","unstructured":"Harrison DJ, Parisi MT, Shulkin BL. The role of 18F-FDG-PET\/CT in pediatric sarcoma. Semin Nucl Med. 2017;47(3):229\u201341.","journal-title":"Semin Nucl Med"},{"issue":"3","key":"130_CR3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.semnuclmed.2017.01.001","volume":"47","author":"R Kluge","year":"2017","unstructured":"Kluge R, Kurch L, Georgi T, Metzger M. Current role of FDG-PET in pediatric Hodgkin's lymphoma. Semin Nucl Med. 2017;47(3):242\u201357.","journal-title":"Semin Nucl Med"},{"issue":"2","key":"130_CR4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.2967\/jnumed.114.146290","volume":"56","author":"L Uslu","year":"2015","unstructured":"Uslu L, Donig J, Link M, Rosenberg J, Quon A, Daldrup-Link HE. Value of 18F-FDG PET and PET\/CT for evaluation of pediatric malignancies. J Nucl Med. 2015;56(2):274\u201386.","journal-title":"J Nucl Med"},{"key":"130_CR5","doi-asserted-by":"crossref","unstructured":"Fahey FH, Goodkind A, MacDougall RD, Oberg L, Ziniel SI, Cappock R, Callahan MJ, Kwatra N, Treves ST, Voss SD. Operational and Dosimetric aspects of pediatric PET\/CT. J Nucl Med. 2017;58(9):1360\u2013366.","DOI":"10.2967\/jnumed.116.182899"},{"issue":"3","key":"130_CR6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.semnuclmed.2017.01.002","volume":"47","author":"MT Parisi","year":"2017","unstructured":"Parisi MT, Bermo MS, Alessio AM, Sharp SE, Gelfand MJ, Shulkin BL. Optimization of pediatric PET\/CT. Semin Nucl Med. 2017;47(3):258\u201374.","journal-title":"Semin Nucl Med"},{"key":"130_CR7","unstructured":"Jacques L, Jensen TS, Rollins J, Caplan S, Roche JC: Decision memo for positron emission tomography (FDG) for solid tumors (CAG-00181R4). Edited by Services CfMaM; 2013."},{"key":"130_CR8","doi-asserted-by":"crossref","unstructured":"Flerlage JE, Kelly KM, Beishuizen A, Cho S, De Alarcon PA, Dieckmann U, Drachtman RA, Hoppe BS, Howard SC, Kaste SC, et al. Staging evaluation and response criteria harmonization (SEARCH) for childhood, adolescent and young adult Hodgkin lymphoma (CAYAHL): methodology statement. Pediatr Blood Cancer. 2017;64(7):e26421\/1-10.","DOI":"10.1002\/pbc.26421"},{"issue":"15","key":"130_CR9","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1002\/cncr.24421","volume":"115","author":"DS Hawkins","year":"2009","unstructured":"Hawkins DS, Conrad EU 3rd, Butrynski JE, Schuetze SM, Eary JF. [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer. 2009;115(15):3519\u201325.","journal-title":"Cancer"},{"issue":"34","key":"130_CR10","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1200\/JCO.2005.01.7079","volume":"23","author":"DS Hawkins","year":"2005","unstructured":"Hawkins DS, Schuetze SM, Butrynski JE, Rajendran JG, Vernon CB, Conrad EU 3rd, Eary JF. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol. 2005;23(34):8828\u201334.","journal-title":"J Clin Oncol"},{"issue":"2","key":"130_CR11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12094-015-1351-6","volume":"18","author":"A Raciborska","year":"2016","unstructured":"Raciborska A, Bilska K, Drabko K, Michalak E, Chaber R, Pogorzala M, Polczynska K, Sobol G, Wieczorek M, Muszynska-Roslan K, et al. Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma. Clin Transl Oncol. 2016;18(2):189\u201395.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"130_CR12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11060-012-0840-5","volume":"108","author":"LL Tsai","year":"2012","unstructured":"Tsai LL, Drubach L, Fahey F, Irons M, Voss S, Ullrich NJ. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation. J Neuro-Oncol. 2012;108(3):469\u201375.","journal-title":"J Neuro-Oncol"},{"issue":"4","key":"130_CR13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/j.semnuclmed.2016.01.004","volume":"46","author":"PO Kiratli","year":"2016","unstructured":"Kiratli PO, Tuncel M, Bar-Sever Z. Nuclear medicine in pediatric and adolescent tumors. Semin Nucl Med. 2016;46(4):308\u201323.","journal-title":"Semin Nucl Med"},{"issue":"4","key":"130_CR14","first-page":"401","volume":"54","author":"C Franzius","year":"2010","unstructured":"Franzius C. FDG-PET\/CT in pediatric solid tumors. Q J Nucl Med Mol Imaging. 2010;54(4):401\u201310.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"5","key":"130_CR15","first-page":"1","volume":"15","author":"M Dumba","year":"2015","unstructured":"Dumba M, Jawad N, McHugh K. Neuroblastoma and nephroblastoma: a radiological review. Cancer Imaging. 2015;15(5):1\u201314.","journal-title":"Cancer Imaging"},{"issue":"1","key":"130_CR16","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1148\/rg.2016150099","volume":"36","author":"SE Sharp","year":"2016","unstructured":"Sharp SE, Trout AT, Weiss BD, Gelfand MJ. MIBG in Neuroblastoma diagnostic imaging and therapy. Radiographics. 2016;36(1):258\u201378.","journal-title":"Radiographics"},{"issue":"8","key":"130_CR17","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2967\/jnumed.108.060467","volume":"50","author":"SE Sharp","year":"2009","unstructured":"Sharp SE, Shulkin BL, Gelfand MJ, Salisbury S, Furman WL. 123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med. 2009;50(8):1237\u201343.","journal-title":"J Nucl Med"},{"issue":"7","key":"130_CR18","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s00259-010-1396-2","volume":"37","author":"AK Moinul Hossain","year":"2010","unstructured":"Moinul Hossain AK, Shulkin BL, Gelfand MJ, Bashir H, Daw NC, Sharp SE, Nadel HR, Dome JS. FDG positron emission tomography\/computed tomography studies of Wilms\u2019 tumor. Eur J Nucl Med Mol Imaging. 2010;37(7):1300\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"130_CR19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/pbc.24533","volume":"60","author":"DA Weiser","year":"2013","unstructured":"Weiser DA, Kaste SC, Siegel MJ, Adamson PC. Imaging in childhood cancer: a Society for Pediatric Radiology and Children's oncology group joint task force report. Pediatr Blood Cancer. 2013;60(8):1253\u201360.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"130_CR20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2214\/AJR.06.0813","volume":"188","author":"TZ Wong","year":"2007","unstructured":"Wong TZ, Paulson EK, Nelson RC, Patz EF Jr, Coleman RE. Practical approach to diagnostic CT combined with PET. AJR Am J Roentgenol. 2007;188(3):622\u20139.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"130_CR21","first-page":"1352","volume":"46","author":"MM Osman","year":"2005","unstructured":"Osman MM, Cohade C, Fishman EK, Wahl RL. Clinically significant incidental findings on the unenhanced CT portion of PET\/CT studies: frequency in 250 patients. J Nucl Med. 2005;46(8):1352\u20135.","journal-title":"J Nucl Med"},{"issue":"2","key":"130_CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cpet.2013.12.002","volume":"9","author":"FD Grant","year":"2014","unstructured":"Grant FD. Normal variations and benign findings in pediatric 18F-FDG-PET\/CT. PET Clin. 2014;9(2):195\u2013208.","journal-title":"PET Clin"},{"issue":"1","key":"130_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1148\/radiol.14131732","volume":"273","author":"JF Schafer","year":"2014","unstructured":"Schafer JF, Gatidis S, Schmidt H, Guckel B, Bezrukov I, Pfannenberg CA, Reimold M, Ebinger M, Fuchs J, Claussen CD, et al. Simultaneous whole-body PET\/MR imaging in comparison to PET\/CT in pediatric oncology: initial results. Radiology. 2014;273(1):220\u201331.","journal-title":"Radiology"},{"issue":"1","key":"130_CR24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RLI.0000000000000200","volume":"51","author":"S Gatidis","year":"2016","unstructured":"Gatidis S, Schmidt H, Gucke B, Bezrukov I, Seitz G, Ebinger M, Reimold M, Pfannenberg CA, Nikolaou K, Schwenzer NF, et al. Comprehensive oncologic imaging in infants and preschool children with substantially reduced radiation exposure using combined simultaneous (1)(8)F-Fluorodeoxyglucose positron emission tomography\/magnetic resonance imaging: a direct comparison to (1)(8)F-Fluorodeoxyglucose positron emission tomography\/computed tomography. Investig Radiol. 2016;51(1):7\u201314.","journal-title":"Investig Radiol"},{"key":"130_CR25","doi-asserted-by":"crossref","unstructured":"Gatidis S, Bender B, Reimold M, Schafer JF. PET\/MRI in children. Eur J Radiol. 2017;94:A64\u2013A70.","DOI":"10.1016\/j.ejrad.2017.01.018"},{"issue":"2","key":"130_CR26","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00259-011-1919-5","volume":"39","author":"P Aschoff","year":"2012","unstructured":"Aschoff P, Plathow C, Beyer T, Lichy MP, Erb G, Oksuz MO, Claussen CD, Pfannenberg C. Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET\/CT imaging. Eur J Nucl Med Mol Imaging. 2012;39(2):316\u201325.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"130_CR27","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00259-005-1784-1","volume":"32","author":"AK Berthelsen","year":"2005","unstructured":"Berthelsen AK, Holm S, Loft A, Klausen TL, Andersen F, Hojgaard L. PET\/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging. 2005;32(10):1167\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"130_CR28","first-page":"15N","volume":"57","author":"ST Treves","year":"2016","unstructured":"Treves ST, Gelfand MJ, Fahey FH, Parisi MT. 2016 update of the north American consensus guidelines for pediatric administered radiopharmaceutical activities. J Nucl Med. 2016;57(12):15N\u20138N.","journal-title":"J Nucl Med"},{"issue":"5","key":"130_CR29","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s00259-014-2731-9","volume":"41","author":"M Lassmann","year":"2014","unstructured":"Lassmann M, Treves ST, Group ESPDHW. Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 north American consensus guidelines. Eur J Nucl Med Mol Imaging. 2014;41(5):1036\u201341.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"130_CR30","first-page":"163","volume":"47","author":"T Hope","year":"2017","unstructured":"Hope T, Phelps A, Behr S, Seo Y, Corbin K, MacKenzie J. Sub-mSv whole body PET\/MRI in pediatric patients. Pediatr Radiol. 2017;47(Suppl 1):163.","journal-title":"Pediatr Radiol"},{"issue":"4","key":"130_CR31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2967\/jnumed.116.186353","volume":"58","author":"MA Lodge","year":"2017","unstructured":"Lodge MA. Repeatability of SUV in oncologic 18F-FDG PET. J Nucl Med. 2017;58(4):523\u201332.","journal-title":"J Nucl Med"},{"issue":"28","key":"130_CR32","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1200\/JCO.2017.73.4830","volume":"35","author":"YP Moss\u00e9","year":"2017","unstructured":"Moss\u00e9 YP, Voss SD, Lim MS, Rolland D, Minard CG, Fox E, Adamson P, Wilner K, Blaney SM, Weigel BJ. Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. J Clin Oncol. 2017; 35(28):3215\u201321.","journal-title":"J Clin Oncol"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-017-0130-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T15:10:53Z","timestamp":1570288253000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-017-0130-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1186\/s40644-017-0130-8","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,7]]},"article-number":"28"}}